A novel protease processing site in the transframe protein of human T-cell leukemia virus type 1 PR76gag-pro defines the N terminus of RT

被引:14
作者
Heidecker, G
Hill, S
Lloyd, PA
Derse, D
机构
[1] NCI Frederick, Basic Res Lab, Frederick, MD 21702 USA
[2] SAIC Frederick Inc, Basic Res Program, Frederick, MD 21702 USA
关键词
D O I
10.1128/JVI.76.24.13101-13105.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The genomic RNA of human T-cell leukemia virus type I encodes three polyproteins, Gag, Gag-Pro, and Gag-Pro-Pol, which are translated as a result of no, one, and two frameshifts, respectively. In this report we demonstrate that the 77 residues encoded at the C terminus of the Gag-Pro precursor can be collectively detected as an 8-kDa transframe protein (TFP) in virions. Mutant viruses with a C-terminally truncated TFP (19, 32, or 50 residues) had essentially a wild-type phenotype in vitro. However, a virus mutant that encoded only the Gag and Gag-Pro-Pol polyproteins due to a mutation in the second frameshift site, and hence did not produce TFP, was noninfectious. Mutation analysis of the proteolytic cleavage site between PR and TFP revealed the presence of an additional site and the existence of a p1 peptide separating protease and TFP. While removal of the cleavage site at the PR-p1 junction had a modest effect on virus replication, mutation of the p1-TFP cleavage site led to noninfectious virus and the loss of reverse transcriptase activity. Determination of the amino-terminal sequence of a hemagglutinin-tagged RT demonstrated that the same site is used in processing the Gag-Pro-Pol precursor and thus defines the start of mature RT. Neither mutation alone or in combination caused changes in the amounts or processing patterns of the Gag polyprotein, indicating that protease is active independent of its C terminus.
引用
收藏
页码:13101 / 13105
页数:5
相关论文
共 18 条
[1]   Proteolytic processing of the human T-cell lymphotropic virus 1 reverse transcriptase: Identification of the N-terminal cleavage site by mass spectrometry [J].
Agbuya, PG ;
Sherman, NE ;
Moen, LK .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 392 (01) :93-102
[2]   Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo [J].
Bartoe, JT ;
Albrecht, B ;
Collins, ND ;
Robek, MD ;
Ratner, L ;
Green, PL ;
Lairmore, MD .
JOURNAL OF VIROLOGY, 2000, 74 (03) :1094-1100
[3]   Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo [J].
Collins, ND ;
Newbound, GC ;
Albrecht, B ;
Beard, JL ;
Ratner, L ;
Lairmore, MD .
BLOOD, 1998, 91 (12) :4701-4707
[4]   DETECTION OF HUMAN T-CELL LEUKEMIA-VIRUS-1 PERMISSIVE CELLS USING CELL-LINES PRODUCING SELECTABLE RECOMBINANT VIRIONS [J].
COPELAND, KFT ;
HAAKSMA, AGM ;
DERSE, D ;
HEENEY, JL .
JOURNAL OF VIROLOGICAL METHODS, 1994, 50 (1-3) :219-225
[5]   ANALYSIS OF SUBSTRATE CLEAVAGE BY RECOMBINANT PROTEASE OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-1 REVEALS PREFERENCES AND SPECIFICITY OF BINDING [J].
DAENKE, S ;
SCHRAMM, HJ ;
BANGHAM, CRM .
JOURNAL OF GENERAL VIROLOGY, 1994, 75 :2233-2239
[6]   X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro [J].
Derse, D ;
Mikovits, J ;
Ruscetti, F .
VIROLOGY, 1997, 237 (01) :123-128
[7]   Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors [J].
Derse, D ;
Hill, SA ;
Lloyd, PA ;
Chung, HK ;
Morse, BA .
JOURNAL OF VIROLOGY, 2001, 75 (18) :8461-8468
[8]   Examining the molecular genetics of HTLV-I with an infectious molecular clone of the virus and permissive cell culture systems [J].
Derse, D ;
Mikovits, J ;
Waters, D ;
Brining, S ;
Ruscetti, F .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 12 (01) :1-5
[9]   Substrates and inhibitors of human T-cell leukemia virus type I protease [J].
Ding, YS ;
Rich, DH ;
Ikeda, RA .
BIOCHEMISTRY, 1998, 37 (50) :17514-17518
[10]  
GESSAIN A, 1985, LANCET, V2, P407